Synopsis
0
CEP/COS
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.
About the Company : Inabata France, established in 1990 and part of the Inabata Group, acquired Pharmasynthèse in 2006. Today, Inabata-Pharmasynthèse offers sourcing, manufacturing, and development ...
Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.
About the Company : Gentec Pharmaceutical Group, with over 40 years of experience, is a leader in raw materials and ingredients for food, dietary, and nutrition sectors. It manufactures and commercial...
Jai Radhe Sales is your partner for all your sourcing needs.
About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dr. Paul Lohmann GmbH & Co. KGaA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Solubilizers
API Stability Enhancers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
36
PharmaCompass offers a list of Bepotastine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Bepotastine manufacturer or Bepotastine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Bepotastine manufacturer or Bepotastine supplier.
A V2224 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of V2224, including repackagers and relabelers. The FDA regulates V2224 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. V2224 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of V2224 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A V2224 supplier is an individual or a company that provides V2224 active pharmaceutical ingredient (API) or V2224 finished formulations upon request. The V2224 suppliers may include V2224 API manufacturers, exporters, distributors and traders.
click here to find a list of V2224 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A V2224 DMF (Drug Master File) is a document detailing the whole manufacturing process of V2224 active pharmaceutical ingredient (API) in detail. Different forms of V2224 DMFs exist exist since differing nations have different regulations, such as V2224 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A V2224 DMF submitted to regulatory agencies in the US is known as a USDMF. V2224 USDMF includes data on V2224's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The V2224 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of V2224 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The V2224 Drug Master File in Japan (V2224 JDMF) empowers V2224 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the V2224 JDMF during the approval evaluation for pharmaceutical products. At the time of V2224 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of V2224 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a V2224 Drug Master File in Korea (V2224 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of V2224. The MFDS reviews the V2224 KDMF as part of the drug registration process and uses the information provided in the V2224 KDMF to evaluate the safety and efficacy of the drug.
After submitting a V2224 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their V2224 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of V2224 suppliers with KDMF on PharmaCompass.
A V2224 written confirmation (V2224 WC) is an official document issued by a regulatory agency to a V2224 manufacturer, verifying that the manufacturing facility of a V2224 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting V2224 APIs or V2224 finished pharmaceutical products to another nation, regulatory agencies frequently require a V2224 WC (written confirmation) as part of the regulatory process.
click here to find a list of V2224 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing V2224 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for V2224 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture V2224 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain V2224 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a V2224 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of V2224 suppliers with NDC on PharmaCompass.
V2224 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of V2224 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right V2224 GMP manufacturer or V2224 GMP API supplier for your needs.
A V2224 CoA (Certificate of Analysis) is a formal document that attests to V2224's compliance with V2224 specifications and serves as a tool for batch-level quality control.
V2224 CoA mostly includes findings from lab analyses of a specific batch. For each V2224 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
V2224 may be tested according to a variety of international standards, such as European Pharmacopoeia (V2224 EP), V2224 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (V2224 USP).
